Hymecromone

Hymecromone

SCHEMBL5499316

Cc1cc(=O)oc2cc(O)ccc12.O=c1cc(C(F)(F)F)c2ccc(O)cc2o1

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B3 P37058 3/20 0.83
▸ CA9 Q16790 5/20 0.75
▸ KDM4E B2RXH2 4/20 0.75
▸ ALDH1A1 P00352 4/20 0.75
▸ GAA P10253 3/20 0.75
▸ HPGD P15428 3/20 0.75
▸ CASP1 P29466 3/20 0.75
▸ CASP7 P55210 3/20 0.75
▸ HSD17B10 Q99714 3/20 0.75
▸ CA12 O43570 3/20 0.75
▸ MCL1 Q07820 2/20 0.75
▸ CYP1A2 P05177 2/20 0.75
▸ GLA P06280 2/20 0.75
▸ MAOB P27338 2/20 0.75
▸ LMNA P02545 1/20 0.75
▸ CYP2C9 P11712 1/20 0.75
▸ AKR1B1 P15121 1/20 0.75
▸ UGT1A1 P22309 1/20 0.75
▸ KDR P35968 1/20 0.75
▸ KMT2A Q03164 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL307508 0.91 HSD17B3 (1.00) HSD17B3CA9KDM4EALDH1A1GAA
SCHEMBL29648420 0.91 HSD17B3 (1.00) HSD17B3CA9KDM4EALDH1A1GAA
Formaldehyde SCHEMBL27728517 0.88 HSD17B3 (0.94) HSD17B3CA9KDM4EALDH1A1GAA
Hymecromone SCHEMBL29624431 0.87 HSD17B3 (1.00) HSD17B3CA9KDM4EALDH1A1GAA
Hymecromone SCHEMBL29364837 0.87 HSD17B3 (1.00) HSD17B3CA9KDM4EALDH1A1GAA
Hymecromone SCHEMBL2357040 0.87 HSD17B3 (1.00) HSD17B3CA9KDM4EALDH1A1GAA
Hymecromone SCHEMBL24150 0.87 HSD17B3 (1.00) HSD17B3CA9KDM4EALDH1A1GAA
Hymecromone SCHEMBL31014 0.85 HSD17B3 (0.96) HSD17B3CA9KDM4EALDH1A1GAA
Hymecromone SCHEMBL27924142 0.85 HSD17B3 (0.96) HSD17B3CA9KDM4EALDH1A1GAA
Hymecromone SCHEMBL28882003 0.84 KDM4E (0.87) HSD17B3CA9KDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1592779-A4 TERMINAL-PHOSPHATE-LABELED NUCLEOTIDES WITH NEW LINKERS GE HEALTHCARE BIO SCIENCES (US) 2007-12-12 — — EP disclosed
EP-1592779-A2 TERMINAL-PHOSPHATE-LABELED NUCLEOTIDES WITH NEW LINKERS Amersham Biosciences Corp. (US) 2005-11-09 — — EP disclosed
WO-2004072238-A2 TERMINAL-PHOSPHATE-LABELED NUCLEOTIDES WITH NEW LINKERS AMERSHAM BIOSCIENCES CORP (US) 2004-08-26 — — WO disclosed
Send feedback